Metagenomi Therapeutics, Inc.

MGX

—

Advanced chart & tools →

Metagenomi Therapeutics, Inc.MGX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.36

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$25.21M

Net income

$-87.87M

Net margin

-348.5%

Gross margin

—

Dividends & financials

Metagenomi Therapeutics, Inc. (MGX) reported revenue of $25.21M and net income of $-87.87M, or $-2.36 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.